These stocks are moving in today's pre-market session Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Stay updated with the stocks that are on the move in today's pre-market session. Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Curious about the stocks that are showing activity after the closing bell on Wednesday? Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Why Inhibikase Therapeutics (IKT) Stock Is Up 50% Today Inhibikase Therapeutics shares are trading higher by 50% during Wednesday's session. The company announced the pricing of an approximately $110 million private placement financing.
IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q2 2024 IKT stock results show that Inhibikase Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q1 2024 IKT stock results show that Inhibikase Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q4 2023 IKT stock results show that Inhibikase Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
